Pharmaceutical composition for viral infections
AssigneeThe Administrators of the Tulane Educational Fund
InventorChad Roy
Life of this patent
Estimating the term…
Abstract
Disclosed herein are topical compositions comprising a quaternary ammonium salt and optionally ammonium chloride and/or stabilized chlorine dioxide. Also disclosed herein are methods of reducing the severity and/or duration of a dermal and or mucosal infection such as herpes or shingles. Also disclosed herein are methods of preventing the spread of a viral infection such as HIV. Also disclosed herein are methods of treating a viral infection such as keratoconjunctivitis.
Claims19
A method of reducing the severity or the duration of the symptoms of a viral infection selected from herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2), and varicella zoster virus (VZV), in a subject in need thereof, the method comprising administering to the subject in need thereof a pharmaceutical composition comprising C12-C14-alkyl(ethylbenzyl)dimethylammonium chloride.
A method of preventing the spread of a viral infection selected from influenza virus, the herpes simplex virus, the human immunodeficiency virus (HIV), the hepatitis B virus, the hepatitis C virus, the human papillomavirus (HPV), the ebolavirus, and an adenovirus, in a subject in need thereof, the method comprising administering to the subject in need thereof a pharmaceutical composition comprising C12-C14-alkyl(ethylbenzyl)dimethylammonium chloride.
Dependencies are inferred from the claim text.